{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:13:06Z","timestamp":1783649586357,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Consanguinity provides shortcuts to identify homozygous recessive mutations. However, deep-intronic variants escape standard sequencing (panel; exome\/WES), and their pathogenicity cannot be inferred from genomic data. We applied WES, long-read genome and long-read-RNA-sequencing (LR-WGS, LR-RNA-Seq) in a Syrian patient with biochemically evident GM2-gangliosidosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      No exonic\n                      <jats:italic>HEXA<\/jats:italic>\n                      ,\n                      <jats:italic>HEXB<\/jats:italic>\n                      and\n                      <jats:italic>GM2A<\/jats:italic>\n                      mutations were found. LR-WGS\/LR-RNA-Seq revealed a homozygous\n                      <jats:italic>HEXB<\/jats:italic>\n                      variant, c.771\u2009+\u2009985G\u2009&gt;\u2009A, activating a 97\u00a0bp pseudo-exon.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Integrative genome and transcriptome sequencing unlocked a deep-intronic, database-annotated\n                      <jats:italic>HEXB<\/jats:italic>\n                      mutation and proved causality. This illustrates the diagnostic challenges in patients from the Middle East with its prevalent consanguinity and hidden (candidate founder) mutations which are potential targets for splice-modulating therapies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40246-026-00995-y","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:17:24Z","timestamp":1781061444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An example for potentially underrated causes of recessive disease in the Greater Middle East: integrative long-read genome and transcriptome sequencing pinpoint a deep-intronic homozygous HEXB candidate founder variant in GM2-gangliosidosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Angelika","family":"Bolte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Velmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Netzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Thimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Tun\u04ab","family":"Tuncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"B\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Hiersche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno J\u00f6rn","family":"Bolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"995_CR1","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/bioinformatics\/btu401","volume":"30","author":"A Magi","year":"2014","unstructured":"Magi A, et al. H3M2: detection of runs of homozygosity from whole-exome sequencing data. Bioinformatics. 2014;30:2852\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btu401.","journal-title":"Bioinformatics"},{"key":"995_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.gim.2021.10.004","volume":"24","author":"PR Gonzales","year":"2022","unstructured":"Gonzales PR, et al. Interpretation and reporting of large regions of homozygosity and suspected consanguinity\/uniparental disomy, 2021 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2022;24:255\u201361. https:\/\/doi.org\/10.1016\/j.gim.2021.10.004.","journal-title":"Genet Med"},{"key":"995_CR3","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson JT, Thorvaldsdottir H, Wenger AM, Zehir A, Mesirov JP. Variant Review with the Integrative Genomics Viewer. Cancer Res. 2017;77:e31\u20134. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0337.","journal-title":"Cancer Res"},{"key":"995_CR4","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.gim.2023.100995","volume":"26","author":"F Guo","year":"2024","unstructured":"Guo F, et al. Evidence from 2100 index cases supports genome sequencing as a first-tier genetic test. Genet Med. 2024;26:100995. https:\/\/doi.org\/10.1016\/j.gim.2023.100995.","journal-title":"Genet Med"},{"key":"995_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ymthe.2024.11.025","volume":"33","author":"IH Ament","year":"2025","unstructured":"Ament IH, DeBruyne N, Wang F, Lin L. Long-read RNA sequencing: A transformative technology for exploring transcriptome complexity in human diseases. Mol Ther. 2025;33:883\u201394. https:\/\/doi.org\/10.1016\/j.ymthe.2024.11.025.","journal-title":"Mol Ther"},{"key":"995_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-026-03988-1","author":"D Wissel","year":"2026","unstructured":"Wissel D, et al. A systematic benchmark of high-accuracy PacBio long-read RNA sequencing for transcript-level quantification. Genome Biol. 2026. https:\/\/doi.org\/10.1186\/s13059-026-03988-1.","journal-title":"Genome Biol"},{"key":"995_CR7","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","volume":"619","author":"J Kim","year":"2023","unstructured":"Kim J, et al. A framework for individualized splice-switching oligonucleotide therapy. Nature. 2023;619:828\u201336. https:\/\/doi.org\/10.1038\/s41586-023-06277-0.","journal-title":"Nature"},{"key":"995_CR8","doi-asserted-by":"publisher","unstructured":"Leal AF, et al. GM2 Gangliosidoses: clinical features, pathophysiological aspects, and current therapies. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21176213.","DOI":"10.3390\/ijms21176213"},{"key":"995_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/ng.3837","volume":"49","author":"R Soemedi","year":"2017","unstructured":"Soemedi R, et al. Pathogenic variants that alter protein code often disrupt splicing. Nat Genet. 2017;49:848\u201355. https:\/\/doi.org\/10.1038\/ng.3837.","journal-title":"Nat Genet"},{"key":"995_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02075-8","author":"I Chekroun","year":"2025","unstructured":"Chekroun I, et al. Genomics of rare diseases in the Greater Middle East. Nat Genet. 2025. https:\/\/doi.org\/10.1038\/s41588-025-02075-8.","journal-title":"Nat Genet"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00995-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00995-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00995-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:35:39Z","timestamp":1781062539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00995-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00995-y","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"MH, CB and HJB are employees of Bioscientia Institute for Medical Diagnostics GmbH, a publicly traded diagnostic company. Authors have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}